trial · primary record
Sonrotoclax
Mantle Cell Lymphoma
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 300 |
| Primary completion | 2032-03-30 |
| Primary endpoint | Progression-Free Survival (PFS) as assessed by Blinded Independent Review Committee (BIRC) |
| Registry ID | NCT06742996 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:35.661Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06742996
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- SONROTOCLAX · approval
- Sonrotoclax · compound